Prevention by sodium 4,5-dihydroxybenzene-1,3-disulfonate (Tiron) of vanadium-induced behavioral toxicity in rats

Biological Trace Element Research

Volumn 69, Issue 3, 1999, Pages 249-259

  Sanchez, Domenec J ^a   Colomina, M Teresa ^a   Domingo, Jose L ^a   Corbella, Jacint ^a  

^a UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

Active avoidance; Open field; Rats; Sodium metavanadate; Tiron

Indexed keywords

TIRON; VANADATE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVOIDANCE BEHAVIOR; BEHAVIOR DISORDER; BODY WEIGHT; CONTROLLED STUDY; DRUG ACTIVITY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PHYSICAL ACTIVITY; RAT; TOXICITY;

ANIMALIA; TIRON;

EID: 0032799358     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02783877     Document Type: Article

References (34)

1. B. K. Hope, A global biogeochemical budget for vanadium, Sci. Total Environ. 141, 1-10 (1994).
2. J. O. Nriagu and J. M. Pacyna, Quantitative assessment of worldwide contamination of air, water and soils by trace metals, Nature 333, 134-139 (1988).
3. D. J. Sanchez, A. Ortega, J. L. Domingo, and J. Corbella, Developmental toxicity evaluation of orthovanadate in the mouse, Biol. Trace Element Res. 30, 219-226 (1991).
4. J. L. Domingo, Vanadium: a review of the reproductive and developmental toxicity, Reprod. Toxicol. 10, 175-182 (1996).
5. M. H. Oster, J. M. Llobet, J. L. Domingo, J. B. German, and C. L. Keen, Vanadium treatment of diabetic Sprague-Dawley rats results in tissue vanadium accumulation and pro-oxidant effects, Toxicology 83, 115-130 (1993).
6. H. Zaporowska and W. Wasilewski, Hematological effects of vanadium on living organisms, Comp. Biochem. Physiol. 102C, 223-231 (1992).
7. M. A. Al-Bayati, S. N. Giri, O. G. Raabe, L. S. Rosenblatt, and M. Shifrine, Time and dose-response study of the effects of vanadate on rats: morphological and biochemical changes in organs, J. Environ. Pathol. Toxicol. Oncol. 9, 435-439 (1989).
8. J. L. Domingo, M. Gomez, D. J. Sanchez, J. M. Llobet, J. Corbella, and C. L. Keen, The marked improvement of glucose homeostasis by oral vanadate or vanadyl treatment in streptozotocin-induced diabetic rats may be related to the anorexic effects of vanadium, Trace Element Electr. 11, 16-22 (1994).
9. C. E. Heyliger, A. G. Tahiliani, and J. H. McNeill, Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats, Science 227, 1474-1477 (1985).
10. A. M. Kordowiak, R. Trzos, and R. Grybos, Insulin-like effects on liver Golgi membrane preparations of bis(oxalato)oxovanadate(IV) complex ion, a new vanadate compound, Horm. Metab. Res. 29, 101-105 (1997).
11. A. K. Srivastava, Potential use of vanadium compounds in the treatment of diabetes mellitus, Exp. Opin. Invest. Drugs 4, 525-536 (1995).
12. E. Tsiani and I. G. Fantus, Vanadium compounds. Biological actions and potential as pharmacological agents, Trends Endocrinol. Metab. 8, 51-58 (1997).
13. J. Yao, M. L. Battell, and J. H. McNeill, Acute and chronic response to vanadium following two methods of streptozotocin-diabetes induction, Can. J. Physiol. Pharmacol. 75, 83-90 (1997).
14. J. L. Domingo, M. Gomez, J. M. Llobet, J. Corbella, and C. L. Keen, Oral vanadium administration to streptozotocin-diabetic rats has marked negative side effects which are independent of the form of vanadium used, Toxicology 66, 279-287 (1991).
15. J. L. Domingo, M. Gomez, J. M. Llobet, J. Corbella, and C. L. Keen, Improvement of glucose homeostasis by oral vanadyl or vanadate treatment in diabetic rats is accompanied by negative side effects, Pharmacol. Toxicol. 68, 249-253 (1991).
16. J. L. Domingo, M. Gomez, D. J. Sanchez, J. M. Llobet, and C. L. Keen, Toxicology of vanadium compounds in diabetic rats: the action of chelating agents on vanadium accumulation, Mol. Cell. Biochem. 153, 233-240 (1995).
17. G. J. Naylor and A. H. W. Smith, Defective control of sodium-pump density in manic depresive psychosis, Psychol. Med. 11, 257-263 (1981).
18. G. J. Naylor, A. H. W. Smith, D. Bryce-Smith, and N. I. Ward, Elevated vanadium content of hair and mania, Biol. Psychiat. 19, 759-764 (1984).
19. G. J. Naylor and A. H. W. Smith, Vanadium: a possible etiological factor in manic depressive illness, Psychol. Med. 11, 249-256 (1981).
20. G. J. Naylor, F. M. Corrigan, A. H. W. Smith, P. Conelly, and N. I. Ward, Further studies of vanadium in depressive psychosi, Br. J. Psychiat. 150, 656-661 (1987).
21. D. J. Sanchez, M. T. Colomina, and J. L. Domingo, Effects of vanadium on activity and learning in rats, Physiol. Behav. 63, 345-350 (1998).
22. B. R. Nechay, Mechanisms of action of vanadium, Ann. Rev. Pharmacol. Toxicol. 24, 501-524 (1984).
23. J. M. Llobet and J. L. Domingo, Acute toxicity of vanadium compounds in rats and mice, Toxicol. Lett. 23, 227-231 (1984).
24. M. Gomez, J. L. Domingo, J. M. Llobet, and J. Corbella, Effectiveness of some chelating agents on distribution and excretion of vanadium in rats after prolonged oral administration, J. Appl. Toxicol. 11, 195-198 (1991).
25. M. Gomez, J. L. Domingo, J. M. Llobet, and J. Corbella, Evaluation of the efficacy of various chelating agents on urinary excretion and tissue distribution of vanadium in rats, Toxicol. Lett. 57, 227-234 (1991).
26. 2+ handling in vascular smooth muscle cells, Trace Element Electr. 13, 109-113 (1996).
27. C. M. Vescina, V. C. Salice, A. M. Cortizo, and S. B. Etcheverry, Effect of vanadium compounds on acid phosphatase activity, Biol. Trace Element Res. 53, 185-191 (1996).
28. G. J. Naylor, Vanadium and affective disorders, Biol. Psychiat. 18, 103-112 (1983).
29. D. S. G. Kay, G. J. Naylor, A. H. W Smith, and C. Greenwood, The therapeutic effect of ascorbic acid and EDTA in manic-depressive psychosis: double-blind comparisons with standard treatments, Psychol. Med. 14, 533-539 (1984).
30. D. Witkowska and J. Brzezinski, Alteration of brain noradrenaline, dopamine and 5-hydroxytryptamine levels during vanadium poisoning, Polish J. Pharmacol. Pharm. 31, 393-398 (1979).
31. J. L. Domingo, M. A. Bosque, M. Luna, and J. Corbella, Prevention by Tiron (sodium 4,5-dihydroxybenzene-1,3-disulfonate) of vanadate-induced developmental toxicity in mice, Teratology 48, 133-138 (1993).
32. J. L. Domingo, M. Gomez, D. J. Sanchez, J. M. Llobet, and C. L. Keen, Tiron administration minimizes the toxicity of vanadate but not its insulin mimetic properties in diabetic rats, Life Sci. 50, 1311-1318 (1992).
33. J. L. Domingo, D. J. Sanchez, M. Gomez, J. M. Llobet, and J. Corbella, Oral vanadate and Tiron treatment of diabetes mellitus in rats: Improvement of glucose homeostasis and negative side effects, Vet. Hum. Toxicol. 35, 495-500 (1993).
34. A. Ortega, D. J. Sanchez, J. J. Domingo, J. M. Llobet, and J. Corbella, Developmental toxicity evaluation of Tiron (sodium 4,5-dihydroxybenzene-1,3-disulfonate) in mice, Res. Commun. Chem. Pathol. Pharmacol. 73, 97-106 (1991).